Reaction Details |
| Report a problem with these data |
Target | Interleukin-1 receptor-associated kinase 4 |
---|
Ligand | BDBM414419 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | IRAK4 Kinase Assay |
---|
IC50 | 3.00±n/a nM |
---|
Citation | Bothe, U; Siebeneicher, H; Schmidt, N; Günther, J; Steuber, H; Bömer, U; Lange, M; Nubbemeyer, R; Ray, NC; Savy, P 2-substituted indazoles, methods for producing same, pharmaceutical preparations that contain same, and use of same to produce drugs US Patent US10435396 Publication Date 10/8/2019 |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Interleukin-1 receptor-associated kinase 4 |
---|
Name: | Interleukin-1 receptor-associated kinase 4 |
Synonyms: | IRAK-4 | IRAK4 | IRAK4_HUMAN | Interleukin-1 receptor-associated kinase 4 (IRAK-4) | Interleukin-1 receptor-associated kinase 4 (IRAK4) | Renal carcinoma antigen NY-REN-64 |
Type: | Protein |
Mol. Mass.: | 51519.08 |
Organism: | Homo sapiens (Human) |
Description: | Q9NWZ3 |
Residue: | 460 |
Sequence: | MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALL
QTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITV
QQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNF
DERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKC
QHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGIN
FLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEAL
RGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMND
ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS
|
|
|
BDBM414419 |
---|
n/a |
---|
Name | BDBM414419 |
Synonyms: | N-[6-Methoxy-2-(tetrahydro-2H-pyran-4-yl)-2H-indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide | US10435396, Example 1 |
Type | Small organic molecule |
Emp. Form. | C20H19F3N4O3 |
Mol. Mass. | 420.3851 |
SMILES | COc1cc2nn(cc2cc1NC(=O)c1cccc(n1)C(F)(F)F)C1CCOCC1 |
Structure |
|